Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Luger

Showing results (11-20 of 311) with videos related to

Pageof 32
Sort By:
Blood|June 12, 2025
Introduction to a Blood Spotlight series on acute myeloid leukemiaSelina M Luger
Drug and Alcohol Review|January 1, 1993
Drug policy: must we choose between harm minimization and abstinence?M Luger, R Batey
Klinische Monatsblatter Fur Augenheilkunde|November 19, 2013
[Visual field loss during pregnancy]M Luger, H Wilhelm
Current Opinion in Hematology|January 15, 2016
Revisiting maintenance therapy in acute myeloid leukemia with novel agentsJonathan Canaani, Selina M Luger
Current Treatment Options in Oncology|January 23, 2017
Minimal Residual Disease in Acute Myeloid LeukemiaPamela J Sung, Selina M Luger
Case Reports in Hematology|August 29, 2012
A paraneoplastic syndrome characterized by extremity swelling with associated inflammatory infiltrate heralds aggressive transformation of myelodysplastic syndromes/myeloproliferative neoplasms to acute myeloid leukemia: a case seriesJames K Mangan, Selina M Luger
Current Treatment Options in Oncology|April 29, 2023
Which Second-Line Tyrosine Kinase Inhibitor(s) for Chronic Myeloid Leukemia?Robert D Schwab, Selina M Luger
Bone Marrow Transplantation|March 15, 2016
Allogeneic transplant for FLT3-ITD+ AML: room for improvementA E Perl, S M Luger
Blood|May 14, 2015
How I treat adults with relapsed or refractory Philadelphia chromosome-negative acute lymphoblastic leukemiaNoelle V Frey, Selina M Luger
Therapeutic Advances in Hematology|April 5, 2013
Salvage therapy for relapsed or refractory acute myeloid leukemiaJames K Mangan, Selina M Luger
Pageof 32

Showing results (11-20 of 311) with videos related to

Sort By:
Pageof 32
Blood|June 12, 2025
Introduction to a Blood Spotlight series on acute myeloid leukemiaSelina M Luger
Drug and Alcohol Review|January 1, 1993
Drug policy: must we choose between harm minimization and abstinence?M Luger, R Batey
Klinische Monatsblatter Fur Augenheilkunde|November 19, 2013
[Visual field loss during pregnancy]M Luger, H Wilhelm
Current Opinion in Hematology|January 15, 2016
Revisiting maintenance therapy in acute myeloid leukemia with novel agentsJonathan Canaani, Selina M Luger
Current Treatment Options in Oncology|January 23, 2017
Minimal Residual Disease in Acute Myeloid LeukemiaPamela J Sung, Selina M Luger
Case Reports in Hematology|August 29, 2012
A paraneoplastic syndrome characterized by extremity swelling with associated inflammatory infiltrate heralds aggressive transformation of myelodysplastic syndromes/myeloproliferative neoplasms to acute myeloid leukemia: a case seriesJames K Mangan, Selina M Luger
Current Treatment Options in Oncology|April 29, 2023
Which Second-Line Tyrosine Kinase Inhibitor(s) for Chronic Myeloid Leukemia?Robert D Schwab, Selina M Luger
Bone Marrow Transplantation|March 15, 2016
Allogeneic transplant for FLT3-ITD+ AML: room for improvementA E Perl, S M Luger
Blood|May 14, 2015
How I treat adults with relapsed or refractory Philadelphia chromosome-negative acute lymphoblastic leukemiaNoelle V Frey, Selina M Luger
Therapeutic Advances in Hematology|April 5, 2013
Salvage therapy for relapsed or refractory acute myeloid leukemiaJames K Mangan, Selina M Luger
Pageof 32